Skip to content
Open access

Integrating Single-Molecule Variant Phenotyping with Clinical Features Predicts Outcomes in KIF1A-Associated Neurological Disorder

Sep 2026 · medRxiv · 0 citations
Medicine

TL;DR

Using KIF1A-associated neurological disorder (KAND) as a model system, single-molecule biophysical phenotyping of 91 pathogenic variants with longitudinal clinical characterization of 343 patients offers a prognostic tool and a stratification strategy for clinical trials.

Read PDF

Similar papers

Aug 2026

Early clinical prediction of neurodevelopmental outcome in KCNQ2-related disorders

These prediction models demonstrate the feasibility of early prognostication in KCNQ2-RD and support future prospective external validation and enable more accurate individualised counselling by integrating clinical and genetic information readily available at time of genetic diagnosis.

E. Van Boxstael, C. Millevert, M. Hairabedian et al. · 0 citations
Open access Sep 2026

Molecular subgroups of ALS patients with distinct survival outcomes identified through plasma proteomics

Cell-type enrichment analysis indicating a broad cellular origin of the circulating proteome, with contributions from nervous system cells, vascular cells, immune cells, and muscle cells, highlights the potential of plasma proteomics for clinically meaningful patient stratification in ALS.

I. Aksoylu, L. Azizi, L. Öijerstedt et al. · 0 citations
Review Open access Aug 2026

AI-Guided Systems Neurogenomics in Neurodevelopmental Disorders

A hypothesis-generating load-capacity framework comprising regulatory load, network capacity, developmental buffering and regulatory network instability is proposed, and the Instability Twin is described as a prospective architecture composed of independently testable patient-specific sub-models rather than an existing...

H. Goel, T. Dudding-Byth, B. Kamien · 0 citations
Open access Sep 2026

Molecular context of pathogenic variants is associated with phenotype and treatment response in SCN8A-related disorders

Clinical heterogeneity in SCN8A-related disorders is patterned along molecular dimensions that go beyond the specific genetic alteration, to include position in the linear channel topology, proximity to post-translational modification (PTM) and structural sites, and predicted effects on mRNA splicing.

Joshua B. Hack, J. Watkins, Michael F. Hammer · 0 citations
Review Open access Aug 2026

Clinical phenotype spectrum and prognostic analysis of DNM1L-related disorders: a single-center cohort study of 18 patients

“hemiconvulsion-hemiplegia-epilepsy syndrome” is identified as a distinct feature and potential prognostic indicator for middle domain variants in DNM1L variants, which are predominantly missense, with the middle domain as a hotspot.

Han Xu, Chao-Long Xu, Ying Zou et al. · 0 citations
Open access Aug 2026

Peripheral blood transcriptomic signature is associated with cognitive impairment and freezing of gait in Parkinson’s disease: a data-driven approach

It is demonstrated that peripheral blood transcriptomic signatures capture aspects of PD pathophysiology that are not fully explained by nigrostriatal dopaminergic degeneration alone, serving as potential prognostic biomarkers for cognitive impairment and FOG.

Reeree Lee, Mincheol Park · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.